400 SPECTRUM CENTER DRIVE, IRVINE, CA
2026 Annual Meeting Results; Directors Elected at CG Oncology, Inc.
CG Oncology, Inc. Announces Separation of President Ambaw Bellete
Reports First Quarter 2026 Financial Results and Provides Business Updates
Annual Report to Security Holders
Appointment of Jim DeTore as Chief Financial Officer
Reports 2025 Year End Financial Results and Provides Business Updates
CG Oncology, Inc. Files Amendment No. 1 for $550 Million Common Stock Offering
Investor Presentation
Q1
FY 2024
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
Amended Registration Statement for Securities
S-1
Definitive Proxy Statement
Additional Proxy Materials
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership